[Motility-effective drugs for therapy of gastrointestinal functional disorders].
D001626:Bethanechol Compounds / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D004294:Domperidone / Q000494:pharmacology; D004942:Esophagitis, Peptic / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000188:drug therapy; D007700:Kinetics; D008688:Methacholine Compounds / Q000494:pharmacology; D008787:Metoclopramide / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D013997:Time Factors
D001626:Bethanechol Compounds; D008688:Methacholine Compounds; D009388:Neostigmine; D004294:Domperidone; C013855:bromopride; D002217:Carbachol; D008787:Metoclopramide
Motilitätswirksame Medikamente zur Behandlung gastrointestinaler Funktionnsstörungen.